In this week’s roundup, there are several interesting reviews. The first is from van der Zee-van den Berg AI (and colleagues with equally long names) on screening for postpartum depression at well-baby visits. From our group, Charlotte Hogan and Marlene Freeman have published a review on the adverse effects of pharmacologic treatment of bipolar disorder during pregnancy. And there is also a review of perinatal depression in the military from Klaman and Turner.
Sipsma HL, Callands T, Desrosiers A, Magriples U, Jones K, Albritton T, Kershaw T.
Matern Child Health J. 2016 Aug 19. [Epub ahead of print]
Summary: In young parents (ages 14-21), predictors of elevated depressive symptoms included inadequate social support and relationship dissatisfaction. In fathers, marijuana use resulted in almost twice the odds of experiencing elevated depressive symptoms (OR 1.82).
Swanson SA, Hernandez-Diaz S, Palmsten K, Mogun H, Olfson M, Huybrechts KF.
Pharmacoepidemiol Drug Saf. 2015 Sep;24(9):934-42.
Soc Sci Med. 2016 Aug 15;166:128-136.
Hogan CS, Freeman MP.
Psychiatr Clin North Am. 2016 Sep;39(3):465-75.
Levine MD, Cheng Y, Marcus MD, Kalarchian MA, Emery RL.
JAMA Intern Med. 2016 Apr;176(4):443-52.
van der Zee-van den Berg AI, Boere-Boonekamp MM, IJzerman MJ, Haasnoot-Smallegange RM, Reijneveld SA.
Matern Child Health J. 2016 Aug 12. [Epub ahead of print]
Klaman SL, Turner K.
Matern Child Health J. 2016 Aug 16. [Epub ahead of print]
Boddy R, Gordon C, Maccallum F, Mcguinness M.
J Adv Nurs. 2016 Aug 17.
Irwin JL, Beeghly M, Rosenblum KL, Muzik M.
Arch Womens Ment Health. 2016 Aug 12. [Epub ahead of print]
Tong VT, Farr SL, Bombard J, D?Angelo D, Ko JY, England LJ.
Obstet Gynecol. 2016 Sep;128(3):562-70.
Belfort MB, Anderson PJ, Nowak VA, Lee KJ, Molesworth C, Thompson DK, Doyle LW, Inder TE.
J Pediatr. 2016 Jul 26.